The connected biosensor is said to automatically and continuously measure the appropriate clinical indications such as heart rate, respiratory rate, skin temperature and others.

The biosensor will then transfers the data to the connected clinical decision support software application, which will advise the appropriate caregiver or clinician when preset limits are crossed.

Philips patient care and monitoring solutions CEO Carla Kriwet said: "Driven by Philips’ strong patient monitoring heritage, we are entering the emerging growth market of mobile health enabled solutions and services.

"We envision a future where patients enabled by connected health technologies will recover faster with fewer complications and greater peace of mind in the hospital and subsequently at home."

Royal Philips is also planning to launch a portfolio of solutions, which will connect to analytics tools and dashboards. They will provide clinicians with actionable insights to help enhance patient outcomes, reduce costs and improve access to care.

With operations in over 100 countries, the company provides cardiac care, acute care and home healthcare solutions to the customers.

Image: Medical-grade and connected biosensor continuously measures clinically relevant vital signs. Photo: courtesy of PRNewsFoto/Royal Philips.